Mario Loriga

Discovery of potent pteridine reductase inhibitors to guide antiparasite drug development

Antonio Cavazzuti, Giuseppe Paglietti, William N. Hunter et al. · Proceedings of the National Academy of Sciences · 2008 · 157 citations · Full text

Crystal Structure, Bioorganic Chemistry, Antiparasitic Agent +17

Synthesis and in vitro antitumor activity of new quinoxaline derivatives

Paola Corona, Antonio Carta, Mario Loriga et al. · European Journal of Medicinal Chemistry · 2008 · 105 citations

Medicinal Chemistry, Derivative (Chemistry), Derivatives +8

Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides

Antonio Carta, Mario Loriga, Giuseppe Paglietti et al. · European Journal of Medicinal Chemistry · 2004 · 102 citations

2-Substituted-6,7-difluoro-3-methylquinoxaline 1,4-Dioxides, Antifungal Agent, Medicine +8

Quinoxaline chemistry. Part 7. 2-[aminobenzoates]- and 2-[aminobenzoylglutamate]-quinoxalines as classical antifolate agents. Synthesis and evaluation of in vitro anticancer, anti-HIV and antifungal activity.

Mario Loriga, Sandra Piras, Paolo Sanna et al. · PubMed · 1997 · 101 citations

Preparation and biological evaluation of 6/7-trifluoromethyl(nitro)-, 6,7-difluoro-3-alkyl (aryl)-substituted-quinoxalin-2-ones. Part 3

Paolo Sanna, Antonio Carta, Mario Loriga et al. · Il Farmaco · 1999 · 64 citations

Pharmacology, Organic Chemistry, Biological Evaluation +1